BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Breakthrough Discoveries on Novel Features of Omicron Variant and An Anti-Omicron Antibody JMB2002

A team of scientists led by Dr. Su-Jun Deng from biologics of Jemincare R&D Center, and another team of scientists from SIMM of CAS, led by P...

January 04, 2022 | News

Ascletis Expands Ritonavir Oral Tablet Production

Ritonavir oral tablet annual production capacity has been expanded to 100 million tablets and can be further rapidly expanded based on market demand - ASC...

January 03, 2022 | News

Siemens Healthineers Announces FDA EUA For CLINITEST® Rapid COVID-19 Antigen Self-Test

Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of COVID-19 exposure. Through nationwide retail d...

December 30, 2021 | News

Covovax Receive EUA for COVID-19 Vaccine in India

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

December 29, 2021 | News

Japan Approves Molnupiravir for the Treatment of SARS-CoV-2 Infection

Japan’s Ministry of Health, Labor and Welfare Approves Molnupiravir for the Treatment of SARS-CoV-2 Infection Molnupiravir, First Oral COVID-19 Anti...

December 27, 2021 | News

WestVac BioPharma COVID-19 vaccine has achieved a significant progress against the Omicron

The vaccine belongs to the latest fifth generation vaccine technology, targeting the S-RBD protein of the COVID-19 mutant strain, the trimer subunit vaccin...

December 27, 2021 | News

Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster

Third dose produced increased immune responses comparable to or exceeding levels associated with protection in Phase 3 clinical trials, with a 9.3-fold IgG...

December 23, 2021 | News

How to Choose the Right At-Home COVID Test

Insight follows announcement that the Biden administration will purchase 500 million rapid COVID-19 tests and distribute free of cost to Americans With th...

December 22, 2021 | News

WHO SAGE Issues Interim Recommendations for Novavax COVID-19 Vaccine

SAGE recommends additional third dose of NVX-CoV2373 administered to immunocompromised persons - Recommendation follows grant of WHO Emergency Use Li...

December 22, 2021 | News

TCM provides new alternatives for the fight against COVID-19

Dr. Chen Zhen, President of the Central and Eastern European Federation of Chinese Medicine Societies, said that the Hungarian Qihuang TCM Center prov...

December 22, 2021 | News

EU Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine

Novavax and the European Commission previously announced an advance purchase agreement for up to 200 million doses through 2023 Authorization follows po...

December 21, 2021 | News

Japan's MHLW Approves Booster Shot for SPIKEVAX®, Moderna's mRNA COVID-19 Vaccine

Brand Institute is proud to announce its successful partnership with Moderna in naming their mRNA COVID-19 vaccine: SPIKEVAX®. The brand nam...

December 20, 2021 | News

MOH Singapore granted Acumen Diagnostics COVID-19 offsite PCR testing license

PCR testing services will be rolled out to an initial 10 clinics by 31 December 2021- Vaccinations and a robust testing regime remain the best strate...

December 16, 2021 | News

Noorik Biopharmaceuticals announces contract for ambrisentan treatment of COVID-19

Noorik Biopharmaceuticals Ltd. ("Noorik"), a clinical-stage biopharmaceutical company repurposing micro-dose ambrisentan for the treatment of kidney, liver...

December 16, 2021 | News

Stay Connected